Atnaujinkite slapukų nuostatas

El. knyga: 2020 Nelson's Pediatric Antimicrobial Therapy

, , , , , , , ,
  • Formatas: 320 pages
  • Išleidimo metai: 15-Jan-2020
  • Leidėjas: American Academy of Pediatrics
  • Kalba: eng
  • ISBN-13: 9781610023535
Kitos knygos pagal šią temą:
2020 Nelson's Pediatric Antimicrobial TherapyDidesnis paveikslėlis
  • Formatas: 320 pages
  • Išleidimo metai: 15-Jan-2020
  • Leidėjas: American Academy of Pediatrics
  • Kalba: eng
  • ISBN-13: 9781610023535
Kitos knygos pagal šią temą:

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

The 26th edition provides practical, evidence-based recommendations from the experts in antimicrobial therapy for treatment of infectious diseases in children. For each disease, the authors provide a commentary to help health care providers select the best of all antimicrobial choices. Drug descriptions cover pediatric-appropriate antimicrobial agents available today and include complete information about dosing regimens.



This best-selling and widely used resource on pediatric antimicrobial therapy provides instant access to reliable, up-to-the-minute recommendations for treatment of infectious diseases in children. For each disease, the authors provide a commentary to help health care providers select the best of all antimicrobial choices.

The 26th edition provides practical, evidence-based recommendations from the experts in antimicrobial therapy for treatment of infectious diseases in children. For each disease, the authors provide a commentary to help health care providers select the best of all antimicrobial choices.

Drug descriptions cover pediatric-appropriate antimicrobial agents available today and include complete information about dosing regimens.

New in the 26th edition:
  • First pediatric approval of beta-lactam/beta-lactamase inhibitor for CRE (carbapenem-resistant enteric bacilli), ceftazidime-avibactam
  • Replacement antibiotics for cefotaxime (lack of availability in the US), including ceftriaxone and cefepime (for neonates)
  • Situations in which ceftaroline is preferred over vancomycin by the Editors for MRSA infections
  • Updates on management of influenza, including baloxavir (now approved for children >12 years)
  • New approaches to treatment of mucomycosis
  • New recommendations for malaria
  • More than 150 new references!

 

Recenzijos

2020 Nelson's Pediatric Antimicrobial Therapy has been selected as one of Doodys Core Titles®

Introduction vii
Notable Changes to 2020 Nelson's Pediatric Antimicrobial Therapy, 26th Edition xi
1 Choosing Among Antibiotics Within a Class: Beta-lactams and Beta-lactamase Inhibitors, Macrolides, Aminoglycosides, and Fluoroquinolones
1(8)
2 Choosing Among Antifungal Agents: Polyenes, Azoles, and Echinocandins
9(10)
3 How Antibiotic Dosages Are Determined Using Susceptibility Data, Pharmacodynamics, and Treatment Outcomes
19(4)
4 Approach to Antibiotic Therapy of Drug-Resistant Gram-negative Bacilli and MethiciIlin-Resistant Staphylococcus aureus
23(8)
5 Antimicrobial Therapy for Newborns
31(32)
A Recommended Therapy for Selected Newborn Conditions
33(22)
B Antimicrobial Dosages for Neonates
55(4)
C Aminoglycosides
59(1)
D Vancomycin
60(1)
E Use of Antimicrobials During Pregnancy or Breastfeeding
60(3)
6 Antimicrobial Therapy According to Clinical Syndromes
63(68)
A Skin and Soft Tissue Infections
66(6)
B Skeletal Infections
72(3)
C Eye Infections
75(4)
D Ear and Sinus Infections
79(3)
E Oropharyngeal Infections
82(3)
F Lower Respiratory Tract Infections
85(13)
G Cardiovascular Infections
98(7)
H Gastrointestinal Infections
105(7)
I Genital and Sexually Transmitted Infections
112(4)
J Central Nervous System Infections
116(5)
K Urinary Tract Infections
121(2)
L Miscellaneous Systemic Infections
123(8)
7 Preferred Therapy for Specific Bacterial and Mycobacterial Pathogens
131(28)
A Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Gram Positive)
132(2)
B Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Gram Negative)
134(2)
C Common Bacterial Pathogens and Usual Pattern of Susceptibility to Antibiotics (Anaerobes)
136(2)
D Preferred Therapy for Specific Bacterial and Mycobacterial Pathogens
138(21)
8 Preferred Therapy for Specific Fungal Pathogens
159(18)
A Overview of More Common Fungal Pathogens and Their Usual Pattern of Antifungal Susceptibilities
160(2)
B Systemic Infections
162(14)
C Localized Mucocutaneous Infections
176(1)
9 Preferred Therapy for Specific Viral Pathogens
177(18)
A Overview of Non-HIV, Non-Hepatitis B or C Viral Pathogens and Usual Pattern of Susceptibility to Antivirals
178(1)
B Overview of Hepatitis B or C Viral Pathogens and Usual Pattern of Susceptibility to Antivirals
178(2)
C Preferred Therapy for Specific Viral Pathogens
180(15)
10 Preferred Therapy for Specific Parasitic Pathogens
195(24)
A Selected Common Pathogenic Parasites and Suggested Agents for Treatment
196(2)
B Preferred Therapy for Specific Parasitic Pathogens
198(21)
11 Alphabetic Listing of Antimicrobials
219(32)
A Systemic Antimicrobials With Dosage Forms and Usual Dosages
221(23)
B Topical Antimicrobials (Skin, Eye, Ear, Mucosa)
244(7)
12 Antibiotic Therapy for Children Who Are Obese
251(4)
13 Sequential Parenteral-Oral Antibiotic Therapy (Oral Step-down Therapy) for Serious Infections
255(2)
14 Antimicrobial Prophylaxis/Prevention of Symptomatic Infection
257(18)
A Postexposure Antimicrobial Prophylaxis to Prevent Infection
259(6)
B Long-term Antimicrobial Prophylaxis to Prevent Symptomatic New Infection
265(1)
C Prophylaxis of Symptomatic Disease in Children Who Have Asymptomatic Infection/Latent Infection
266(3)
D Surgical/Procedure Prophylaxis
269(6)
Appendix: Nomogram for Determining Body Surface Area 275(2)
References 277(24)
Index 301
Daugiau apie elektronines knygas Daugiau apie elektronines knygas
Pastovi nuoroda: https://www.kriso.lt/db/97816100235352e.html
Raktažodžiai: